When considering combinations to use, the potential impact of the drug or drugs on potassium levels should be assessed, as hyperkalemia has been shown to occur in around 10% of patients with CKD receiving RAAS inhibitors in clinical practice [55, 56]
Drd2 -floxed mice were created by Shanghai Research Center for Model Organisms
Post-surgical gastroparesis can develop any time after surgery
Retatrutide is explored under medical guidance as part of a personalized care plan
Many patients and providers view GLP-1 therapy similarly to antihypertensive or statin use: stopping creates the same disease risk that existed before
For individuals living with complex, chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), mast cell activation syndrome (MCAS), and dysautonomia, understanding and supporting the body's natural detoxification pathways is a crucial step in symptom management